Now I really dont understand.
Doctors, can you clarify ada ke tak vaksin for Influenza A (H1N1)?http://www.h1n1.net.my/Written by: admin 21/08/2009 09:36:15
“Kempen Klinik Cegah & Rawat Influenza A(H1N1)” (KCRh1n1)
Alriz and Ranbaxy, with the support of MOH, have launched a Campaign to help Malaysian to access to antiviral treatment for Influenza A(H1N1) with greater ease and at lower cost, at the participating private clinics throughout Malaysia.
The Campaign was launched in Kuala Lumpur today by Minister of Health, Dato Sri Liow Tiong Lai.
Under this Campaign, participating clinics can obtain supply of Fluhalt, an Oseltamivir Phosphate capsule manufactured by Ranbaxy at a significantly reduced price.
Oseltamivir Phosphate is an antiviral for prophylaxis and treatment of Influenza A(H1N1). The Ministry of Health recent Guidelines recommended that antiviral be given under the following circumstance:-
Patients with ILI and in the High Risk Group
Patients with fever more than 38°C for two days and above
Patients tested positive with Influenza A.
Public with flu symptoms are advised to seek help from medical doctors.
Alriz and Ranbaxy, will sign up thousand of clinics throughout Malaysia following the launch of the Campaign. A website www.h1n1.net.my have been put in place to provide information to the public on Influenza A(H1N1) as well as to allow public to locate the participating Clinics nearer their respective localities. Educational materials will also be made available at the participating clinics to help public to deal with Influenza A(H1N1).
The Campaign was initiated following the call of the Minister of Health, Dato’ Sri Liow Tiong Lai, for all Malaysian to contribute and participate in stopping the spread of Influenza A(H1N1), which have caused many deaths.
In his speech, Datuk Dr. Rahman Ismail, Managing Director of Alriz Sdn Bhd have commended Ranbaxy (M) Sdn Bhd, for their willingness to participate in this socially benefiting programme by significantly lowered their usual price of the antiviral, to make the Campaign possible. He also commended the efforts and hard work of the Health Minister and his staff in MOH, in dealing with the pandemic. He hope that the doctors in the private clinics and the public will take the Campaign positively, and more doctors in private clinics will come forward to contribute their skill and expertise, to help in the treatment of Influenza A(H1N1) in this pandemic situation. He feels that it would be most difficult, if treatments of Influenza A(H1N1) are left entirely to the public hospitals as the number of patients can overwhelm those hospitals, causing the service standard to drop and difficult for public to seek timely and appropriate treatments.
He further said that the use of antiviral in treatment of influenza is widely practiced oversea, the renowned world opinion is that early treatment of Influenza with antiviral, will help reduce the symptoms, help people to get well sooner as well as reduce chances of causing other complications.
Dato’ Abdullah Mohd Yusof, Chairman of Ranbaxy, informed that his company produced its own API for Oseltamivir. Fluhalt is produced in Malaysia and Ranbaxy is a major supplier of Oseltamivir to Malaysian Government, the product is also exported to many countries oversea. He informed that the supply of the raw material, is becoming more restricted due to increasing demand in the world. However, Ranbaxy has kept some stock for Malaysian needs and his company will also step up the production to help relieve the shortage in the supply of Oseltamivir in Malaysia. There will be adequate supply for the participating clinics of the Campaign with immediate effect.
Minister of Health, YB Dato Sri Liow Tiong Lai, in his speech, praised the efforts of Alriz and Ranbaxy in initiating Klinik Cegah dan Rawat Influenza A(H1N1).”Instead of raising the price, they have agreed with MOH to bring down the price of the antiviral at their own initiatives to help our people in this pandemic situation. They have taken their efforts one step further to organize the private clinics to provide treatment to the public in a well considered approach, using the help of the doctors as well as technology.
Prior to this Campaign, the usual cost for this antiviral drug at the private clinics, is more than RM180.00. As a result of lower supply cost and support from the participating private clinics, the said this antiviral, Fluhalut, Oseltamivir Phospate, will be available to the patients at a reduced price of RM80.00 for a box (10 capsules) at all the participating Clinics. These participating Clinics can be identified by the sign labeled as “ Klinik Cegah dan Rawat Influenza A(H1N1)” displayed at the door of the clinics. The price of RM80.00 is for the antiviral only and does not include consultancy charges of the doctors and charges for other medications.
Dato Sri Liow also encouraged private clinics and hospitals to participate actively in the Campaign, and also to lower treatment charges for patient with ILI where possible, to help the public to cope with Influenza A(H1N1) and also help MOH in fighting Influenza A(H1N1).
“The efforts of the Government in fighting Influenza A(H1N1) will not be spared, the government will continue to give antiviral treatment for the Influenza patients at public hospitals and will continue to do its best”. However, with the current numbers of government’s hospitals and clinics, he said that it is insufficient to treat all the H1N1 patients and other cases. "We have about 7,000 private hospitals and clinics, and if all of them respond to the government’s call, then we will have a very strong force to face the pandemic and further control the spread of Influenza A(H1N1)" Dato Sri Liow said in his opening speech before officiating the campaign.
20th August 2009